Lucira Health, Inc.

2022 Q3 Form 10-Q Financial Statement

#000095017022017439 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $39.77M $74.96M $120.6M
YoY Change -66.09% -53.63% -36.49%
Cash & Equivalents $39.80M $75.00M $121.8M
Short-Term Investments
Other Short-Term Assets $3.350M $5.573M $14.99M
YoY Change -66.77% -8.62% 7.86%
Inventory $55.63M $119.6M $72.91M
Prepaid Expenses $2.506M $4.449M $10.40M
Receivables $14.39M $8.723M $38.86M
Other Receivables $4.824M $7.247M $12.78M
Total Short-Term Assets $120.5M $220.5M $260.1M
YoY Change -37.54% 2.13% 17.21%
LONG-TERM ASSETS
Property, Plant & Equipment $48.30M $46.78M $39.95M
YoY Change 79.17% 66.17% 51.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $772.0K $1.060M $1.059M
YoY Change 215.1% 3319.35%
Total Long-Term Assets $68.71M $68.51M $44.27M
YoY Change 129.61% 138.22% 63.36%
TOTAL ASSETS
Total Short-Term Assets $120.5M $220.5M $260.1M
Total Long-Term Assets $68.71M $68.51M $44.27M
Total Assets $189.2M $289.0M $304.4M
YoY Change -15.08% 18.12% 22.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $25.17M $24.58M $23.14M
YoY Change 140.82% 268.41% 131.37%
Accrued Expenses $55.03M $31.16M $45.41M
YoY Change 262.2% 66.88% 522.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $82.52M $57.93M $70.00M
YoY Change 200.78% 102.3% 294.19%
LONG-TERM LIABILITIES
Long-Term Debt $29.41M $29.21M $29.02M
YoY Change
Other Long-Term Liabilities $16.37M $16.83M $712.0K
YoY Change 1099.93% 6524.8% 137.33%
Total Long-Term Liabilities $29.41M $29.21M $29.02M
YoY Change 2056.01% 11401.18% 9574.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $82.52M $57.93M $70.00M
Total Long-Term Liabilities $29.41M $29.21M $29.02M
Total Liabilities $128.3M $104.0M $99.73M
YoY Change 345.47% 259.89% 452.7%
SHAREHOLDERS EQUITY
Retained Earnings -$264.0M -$137.1M -$115.5M
YoY Change 118.72% 47.1% 50.0%
Common Stock $40.00K $40.00K $40.00K
YoY Change 2.56% 2.56%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $60.89M $185.1M $204.6M
YoY Change
Total Liabilities & Shareholders Equity $189.2M $289.0M $304.4M
YoY Change -15.08% 18.12% 22.26%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Trading Symbol
TradingSymbol
LHDX
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001652724
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39976
dei Entity Registrant Name
EntityRegistrantName
Lucira Health, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2491037
dei Entity Address Address Line1
EntityAddressAddressLine1
1412 62nd Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Emeryville
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94608
dei City Area Code
CityAreaCode
510
dei Local Phone Number
LocalPhoneNumber
350-8071
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
40106495
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74957000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105982000
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8723000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27245000
CY2022Q2 us-gaap Inventory Net
InventoryNet
119576000
CY2021Q4 us-gaap Inventory Net
InventoryNet
50776000
CY2022Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
7247000
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
8188000
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4449000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10274000
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
5573000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3817000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
220525000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
206282000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46782000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30974000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18726000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2714000
CY2022Q2 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
1943000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1060000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
384000
CY2022Q2 us-gaap Assets
Assets
289036000
CY2021Q4 us-gaap Assets
Assets
240354000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
24584000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19371000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31160000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29162000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2185000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1609000
CY2021Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
189000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
57929000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
50331000
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29213000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16827000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1220000
CY2022Q2 us-gaap Liabilities
Liabilities
103969000
CY2021Q4 us-gaap Liabilities
Liabilities
51551000
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
40081464
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
40081464
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39663645
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39663645
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
40000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
40000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
322167000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
317304000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-137140000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128541000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
185067000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
188803000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
289036000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
240354000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26146000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12439000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
116620000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16955000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18154000
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12505000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
68712000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17873000
CY2022Q2 us-gaap Gross Profit
GrossProfit
7992000
CY2021Q2 us-gaap Gross Profit
GrossProfit
-66000
us-gaap Gross Profit
GrossProfit
47908000
us-gaap Gross Profit
GrossProfit
-918000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10753000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10117000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22948000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16399000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18628000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6100000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
32537000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12200000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
29381000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
16217000
us-gaap Operating Expenses
OperatingExpenses
55485000
us-gaap Operating Expenses
OperatingExpenses
28599000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-21389000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-16283000
us-gaap Operating Income Loss
OperatingIncomeLoss
-7577000
us-gaap Operating Income Loss
OperatingIncomeLoss
-29517000
CY2022Q2 lhdx Investment Income And Other Nonoperating Income Expense
InvestmentIncomeAndOtherNonoperatingIncomeExpense
281000
CY2021Q2 lhdx Investment Income And Other Nonoperating Income Expense
InvestmentIncomeAndOtherNonoperatingIncomeExpense
83000
lhdx Investment Income And Other Nonoperating Income Expense
InvestmentIncomeAndOtherNonoperatingIncomeExpense
343000
lhdx Investment Income And Other Nonoperating Income Expense
InvestmentIncomeAndOtherNonoperatingIncomeExpense
1000
CY2022Q2 us-gaap Interest Expense
InterestExpense
826000
us-gaap Interest Expense
InterestExpense
1363000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-545000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
83000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1020000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21934000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16200000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8597000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29516000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-257000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-21677000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16200000
us-gaap Net Income Loss
NetIncomeLoss
-8599000
us-gaap Net Income Loss
NetIncomeLoss
-29516000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39928451
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39928451
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38483766
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38483766
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39839834
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39839834
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30688349
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30688349
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
204632000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
29000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2083000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-21677000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
185067000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
230912000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
143000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
945000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16200000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
215800000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
188803000
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
494000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
121000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
300000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3948000
us-gaap Net Income Loss
NetIncomeLoss
-8599000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
185067000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-62308000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
121080000
lhdx Stock Issued During Period Value Convertible Notes In To Common Stock
StockIssuedDuringPeriodValueConvertibleNotesInToCommonStock
24982000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
159899000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
190000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1473000
us-gaap Net Income Loss
NetIncomeLoss
-29516000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
215800000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
13635000
us-gaap Profit Loss
ProfitLoss
-8599000
us-gaap Profit Loss
ProfitLoss
-29516000
us-gaap Share Based Compensation
ShareBasedCompensation
3424000
us-gaap Share Based Compensation
ShareBasedCompensation
1473000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-55000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
259000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3275000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
882000
lhdx Accretion And Amortization Of Term Loans Discount
AccretionAndAmortizationOfTermLoansDiscount
308000
lhdx Remeasurement Of Derivative Liabilities And Convertible Notes
RemeasurementOfDerivativeLiabilitiesAndConvertibleNotes
281000
us-gaap Paid In Kind Interest
PaidInKindInterest
3000
lhdx Noncash Lease Expense
NoncashLeaseExpense
171000
lhdx Noncash Lease Expense
NoncashLeaseExpense
-11000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
68276000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31317000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18577000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3358000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-941000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-91000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5825000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8767000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1863000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3129000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
362000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2678000
lhdx Increase Decrease In Contract With Customer Refund Liability
IncreaseDecreaseInContractWithCustomerRefundLiability
-189000
lhdx Increase Decrease In Contract With Customer Refund Liability
IncreaseDecreaseInContractWithCustomerRefundLiability
2916000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2027000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-44072000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-47622000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14227000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8977000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14227000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8977000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
29570000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
740000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
159899000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
87000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
150000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
300000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29217000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
160049000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29082000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
103450000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
105982000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
60550000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
76900000
lhdx Interest Expense Debt Excluding Other Interest Expense
InterestExpenseDebtExcludingOtherInterestExpense
1435000
CY2022Q2 us-gaap Revenues
Revenues
26100000
us-gaap Revenues
Revenues
116600000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75000000.0
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-137100000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
74957000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161662000
CY2022Q2 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
1943000
CY2021Q2 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
2338000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
76900000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
164000000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
16000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000
us-gaap Interest Paid Net
InterestPaidNet
771000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
4856000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
650000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
16460000
lhdx Issuance Of Warrants In Connection With Term Loan
IssuanceOfWarrantsInConnectionWithTermLoan
494000
lhdx Vesting Of Early Exercise Options
VestingOfEarlyExerciseOptions
34000
lhdx Vesting Of Early Exercise Options
VestingOfEarlyExerciseOptions
40000
lhdx Stock Based Compensation Expense Capitalized To Inventory
StockBasedCompensationExpenseCapitalizedToInventory
913000
lhdx Stock Based Compensation Expense Capitalized To Inventory
StockBasedCompensationExpenseCapitalizedToInventory
260000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
24982000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
121080000
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2013-02-20
us-gaap Net Income Loss
NetIncomeLoss
-8600000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
13100000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-21700000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> </span></p><p style="text-indent:5.2%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">Significant estimates and assumptions made in the accompanying financial statements include, but are not limited to recognition of stock-based compensation, incremental borrowing rate,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">revenue recognition, inventory valuation,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">sales returns, warranty reserves, allowance for doubtful accounts, accrued research and development costs, uncertain tax positions, the</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;min-width:fit-content;">recoverability of its long-lived assets and the valuation of deferred tax assets. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could materially differ from those estimates.</span></p>
lhdx Redeemable Convertible Preferred Stock Redemption Period After Occurrence Of Certain Liquidation Events
RedeemableConvertiblePreferredStockRedemptionPeriodAfterOccurrenceOfCertainLiquidationEvents
P90D
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
75000000.0
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
106000000.0
CY2022Q2 us-gaap Restricted Cash Equivalents
RestrictedCashEquivalents
1900000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26146000
lhdx Allowance For Doubtful Accounts Receivable Recoveries Write Off
AllowanceForDoubtfulAccountsReceivableRecoveriesWriteOff
-104000
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
options to extend
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12439000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
116620000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16955000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
26146000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
12439000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
116620000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16955000
CY2022Q2 us-gaap Other Commitment
OtherCommitment
57700000
lhdx Forecast Rolling Period
ForecastRollingPeriod
P12M
lhdx Each Forecast Required Period
EachForecastRequiredPeriod
P4M
CY2020Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
24694000
lhdx Change In Fair Value Of Instruments And Accrued Interest Net
ChangeInFairValueOfInstrumentsAndAccruedInterestNet
288000
lhdx Extinguishment Of Instruments Held At Fair Value
ExtinguishmentOfInstrumentsHeldAtFairValue
24982000
CY2022Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
65672000
CY2021 lhdx Allowance For Doubtful Accounts Receivable Recoveries Write Off
AllowanceForDoubtfulAccountsReceivableRecoveriesWriteOff
259000
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
55000
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
35923000
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
40450000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
10539000
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13454000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4314000
CY2022Q2 us-gaap Inventory Net
InventoryNet
119576000
CY2021Q4 us-gaap Inventory Net
InventoryNet
50776000
CY2022Q2 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
2500000
CY2021Q4 us-gaap Inventory Raw Materials And Purchased Parts Net Of Reserves
InventoryRawMaterialsAndPurchasedPartsNetOfReserves
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
900000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
300000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54894000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35811000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8112000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4837000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46782000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30974000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1700000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3300000
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
700000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
900000
us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
700000
CY2022Q2 us-gaap Noncurrent Assets
NoncurrentAssets
65508000
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
33688000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
99000
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
588000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
99000
CY2022Q2 lhdx Prepaid Inventory
PrepaidInventory
408000
lhdx Allowance For Doubtful Accounts Receivable Amounts Charged To Costs And Expenses Recoveries
AllowanceForDoubtfulAccountsReceivableAmountsChargedToCostsAndExpensesRecoveries
-148000
CY2021 lhdx Allowance For Doubtful Accounts Receivable Amounts Charged To Costs And Expenses Recoveries
AllowanceForDoubtfulAccountsReceivableAmountsChargedToCostsAndExpensesRecoveries
358000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
300000
CY2021Q4 lhdx Prepaid Inventory
PrepaidInventory
9379000
CY2022Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
7247000
CY2021Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
8188000
CY2022Q2 us-gaap Prepaid Taxes
PrepaidTaxes
1250000
CY2021Q4 us-gaap Prepaid Taxes
PrepaidTaxes
307000
CY2022Q2 us-gaap Prepaid Insurance
PrepaidInsurance
2791000
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4449000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10274000
CY2022Q2 lhdx Prepaid Inventories Current
PrepaidInventoriesCurrent
400000
CY2021Q4 lhdx Prepaid Inventories Current
PrepaidInventoriesCurrent
9400000
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1955000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
612000
CY2022Q2 lhdx Accrued Manufacturing And Inventory Purchases Current
AccruedManufacturingAndInventoryPurchasesCurrent
14756000
CY2021Q4 lhdx Accrued Manufacturing And Inventory Purchases Current
AccruedManufacturingAndInventoryPurchasesCurrent
17200000
CY2022Q2 lhdx Accrued Canada Importation Taxes Current
AccruedCanadaImportationTaxesCurrent
2717000
CY2021Q4 lhdx Accrued Canada Importation Taxes Current
AccruedCanadaImportationTaxesCurrent
1551000
CY2022Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
5426000
CY2021Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
4466000
CY2022Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
339000
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
1662000
CY2022Q2 lhdx Accrued Sales Taxes Current
AccruedSalesTaxesCurrent
1787000
CY2021Q4 lhdx Accrued Sales Taxes Current
AccruedSalesTaxesCurrent
2215000
CY2022Q2 lhdx Accrued Early Exercise Liability Current
AccruedEarlyExerciseLiabilityCurrent
155000
CY2021Q4 lhdx Accrued Early Exercise Liability Current
AccruedEarlyExerciseLiabilityCurrent
189000
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
247000
CY2022Q2 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
1744000
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2034000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1267000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31160000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
29162000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2994000
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1200000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8100000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
8100000
CY2022Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
700000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8600000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
8600000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
944000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2991000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2922000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2899000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
17010000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
29760000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10748000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
19012000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2185000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16827000
us-gaap Operating Lease Payments
OperatingLeasePayments
1100000
us-gaap Operating Lease Payments
OperatingLeasePayments
200000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
872000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
109000
us-gaap Operating Lease Cost
OperatingLeaseCost
1324000
us-gaap Operating Lease Cost
OperatingLeaseCost
218000
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
320000
CY2021Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
312000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
323000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
627000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y11M12D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M25D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0936
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0715
CY2022Q1 lhdx Lessor Facility Leases Amendment Description
LessorFacilityLeasesAmendmentDescription
In March 2022, the Company executed an amendment with the lessor of two of its facility leases which included an extension of the expiration date of the original leased premise for one location and a reduction of the lease term on another location, such that the lease terms are coterminous on June 30, 2022. Upon the execution of the amendment, which was deemed to be a lease modification, the Company remeasured the lease liability and corresponding right-of-use asset as of the effective date of the amendment to reflect the extended term and recorded $0.2 million a reduction of the respective right-of-use assets and lease liabilities as of the effective date of the amendments.
CY2022Q1 lhdx Facility Lease Reduction Of Right Of Use Assets
FacilityLeaseReductionOfRightOfUseAssets
200000
CY2022Q1 lhdx Facility Lease Reduction Of Lease Liabilities
FacilityLeaseReductionOfLeaseLiabilities
200000
CY2022Q2 lhdx Contractual Coupon
ContractualCoupon
716000
lhdx Contractual Coupon
ContractualCoupon
1127000
CY2022Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
191000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
308000
CY2022Q2 lhdx Interest Expense Debt Excluding Other Interest Expense
InterestExpenseDebtExcludingOtherInterestExpense
907000
CY2022Q2 us-gaap Interest Expense Other
InterestExpenseOther
28000
us-gaap Interest Expense Other
InterestExpenseOther
37000
CY2022Q2 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
109000
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
109000
CY2022Q2 us-gaap Interest Expense
InterestExpense
826000
us-gaap Interest Expense
InterestExpense
1363000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Under the Loan Agreement, as amended, the Company is precluded from the payment of dividends. The holder of each share of common stock is entitled to one vote.
CY2022Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
14969467
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9388184
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1736000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
945000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3424000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1473000
CY2022Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
500000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
900000
CY2021Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
200000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
300000
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
2083000
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
945000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
3948000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1
SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
1473000
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
23900000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3712274
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.30
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y1M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
23150000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
416213
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.85
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
60494
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
119422
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.39
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3948571
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.05
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M12D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1542000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3948571
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
3.05
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y2M12D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
1542000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1928654
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.40
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y9M18D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
1132000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
578211
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1200000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-300000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000.0
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1100000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-21677000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16200000
us-gaap Net Income Loss
NetIncomeLoss
-8599000
us-gaap Net Income Loss
NetIncomeLoss
-29516000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39928451
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39928451
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38483766
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38483766
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39839834
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39839834
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30688349
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30688349
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.54
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.54
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.42
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7435955
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6205388
CY2022Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0.0
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0.0
CY2021Q2 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0.0
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0.0
lhdx Shelf Life Of Covid19 Test Kit
ShelfLifeOfCOVID19TestKit
P12M

Files In Submission

Name View Source Status
0000950170-22-017439-index-headers.html Edgar Link pending
0000950170-22-017439-index.html Edgar Link pending
0000950170-22-017439.txt Edgar Link pending
0000950170-22-017439-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lhdx-20220630.htm Edgar Link pending
lhdx-20220630.xsd Edgar Link pending
lhdx-ex10_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lhdx-20220630_cal.xml Edgar Link unprocessable
lhdx-20220630_def.xml Edgar Link unprocessable
lhdx-20220630_lab.xml Edgar Link unprocessable
lhdx-20220630_pre.xml Edgar Link unprocessable
lhdx-20220630_htm.xml Edgar Link completed
lhdx-ex31_1.htm Edgar Link pending
lhdx-ex31_2.htm Edgar Link pending
lhdx-ex32_1.htm Edgar Link pending
lhdx-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending